Results 201 to 210 of about 564,337 (266)

Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy. [PDF]

open access: yesJ Immunother Cancer
Redavid AR   +4 more
europepmc   +1 more source

Marburg Virus Glycoprotein Is a Remarkable Virulent Factor Linked to Hemorrhagic Pathology: Evidence from Multimodal Experimental Systems

open access: yesAdvanced Science, EarlyView.
By integrating data from in vitro, ex vivo, and in vivo models, our research identifies the MARV glycoprotein as a remarkable hemorrhagic factor, filling a major gap in this important field. It also provides practical experimental tools for the basic research on viral pathogenesis and applied research aimed at antiviral intervention for hemorrhagic ...
Ting Yao   +11 more
wiley   +1 more source

rWTC‐MBTA Vaccine, Alone and Enhanced with Anti‐PD1, Elicits Immune Responses against CNS and Peripheral B‐Cell Lymphoma

open access: yesAdvanced Science, EarlyView.
An autologous whole‐tumor‐cell vaccine (rWTC‐MBTA) is evaluated in murine CNS lymphoma. Subcutaneous vaccination activates dendritic cells, broadens T‐cell priming, and drives lymphocyte trafficking to brain tumors, producing durable tumor control. Longitudinal bioluminescence and adoptive‐transfer assays verify CNS engagement. Combination with anti‐PD‐
Yaping Zhang   +10 more
wiley   +1 more source

SPARC modulates macrophage-like phenotype transformation in VSMCs and triggers a vicious cycle. [PDF]

open access: yesFront Cell Dev Biol
Ye G   +7 more
europepmc   +1 more source

Engineering Osteoimmune Responses with Functionalized Orthopedic Implants for Post‐Operative Osteosarcoma Treatment

open access: yesAdvanced Science, EarlyView.
Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong   +6 more
wiley   +1 more source

Macrophage-derived long non-coding RNAs in cancer: pioneering targets for immune modulation and personalized therapy. [PDF]

open access: yesFront Immunol
Ramalingam PS   +11 more
europepmc   +1 more source

Titanium Dioxide Particle Size Influences Macrophage Signal Switch Towards Osteogenesis In Vitro. [PDF]

open access: yesInt Dent J
Aghila Rani KG   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy